The Healthcare Innovation Cycle
A 10-stage framework for navigating healthcare innovation from unmet need to standard of care — across four parallel dimensions of development.
▾
About the Framework
Developed from CIMIT's 20+ years of direct experience with healthcare innovation teams — tracking progress across four parallel domains from unmet need to standard of care.
The Healthcare Innovation Cycle maps ten Innovation Maturity Levels across four parallel domains of development.
The Healthcare Innovation Cycle (HIC) is a 10-stage framework developed from CIMIT's more than 20 years of experience working directly with healthcare innovation teams, built from patterns observed across hundreds of innovation journeys, from earliest-stage idea through widespread standard-of-care adoption.
The framework organises the innovation journey into ten Innovation Maturity Levels (IMLs) and tracks progress across four domains simultaneously: Clinical/Workflow, Market/Business, Regulatory, and Technical/Science. This structure makes it possible to see at a glance where a project is genuinely strong and where it carries unresolved risk.
▾
Why This Matters
Technology advancing ahead of clinical, commercial, and regulatory dimensions is the most common pattern that derails promising innovations — the HIC makes this risk visible from the outset.
One of the most common patterns that dooms or derails even the most promising healthcare innovations is technological overemphasis. A team advances rapidly in the Technical/Science dimension (the technology works, the science is strong) while the clinical, regulatory, and commercial dimensions lag behind.
This creates a deceptively strong-looking project: important science, genuine technical progress, and real enthusiasm. But great science without parallel clinical validation, a defined regulatory pathway, and a credible commercial model does not produce a commercially viable product or service. The investment compounds, the team grows, and the reckoning arrives late, when the cost of course correction is highest.
The HIC makes this risk visible from the outset by requiring teams to track progress across all four domains simultaneously, at every stage. A quick look at a completed cycle would show that the team is working on Technical Deliverables in IML 5 while still having incomplete Market/Business or Regulatory Deliverables at IML 1, highlighting the significant commercialisation risk for all to see.
▾
The Framework Explained
A short video introduction to the Healthcare Innovation Cycle, produced with EIT Health support.
This video introduces the Healthcare Innovation Cycle and explains how the ten stages and four domains work together.
▾
The 10 Innovation Maturity Levels
Each IML defines what must be demonstrated across all four domains — from identifying an unmet clinical need through achieving standard-of-care adoption.
Progress through the IMLs is not always sequential — work in different domains often advances at different rates — but each level has a clear definition of what must be demonstrated. The detail of what is required at each IML, for each solution type, is documented in the GAITS platform Deliverables.
Clinical Need
Insights into unmet medical needs and available solutions. Identify and validate a genuine unmet clinical problem — documenting who is affected, in what care setting, and why existing approaches are insufficient.
Idea
Potential solution to the unmet need described, evaluated, and selected. Generate and screen concepts against the specific characteristics of the need, the feasibility of the underlying science, and realistic execution scope.
Proof of Concept
Key component concepts validated in models and value proposition tested. Bench or simulation-level evidence that the fundamental approach is technically viable — not a product, but a demonstration of the enabling principle.
Proof of Feasibility
Feasibility of the whole solution demonstrated in models and in feedback from stakeholders. A working prototype shows the concept can function reliably in conditions approaching real-world use.
Proof of Value
The potential of the solution to work and create value for stakeholders is demonstrated. Animal or first-in-human experiments, 100+ clinical stakeholder engagements, KOL feedback, a medical advisory board, and initial seed investment mark this level.
Initial Clinical Trials
Regulated production of prototypes and collection of clinical and economic data. Endpoints are achieved in pilot clinical trials; peer-reviewed publications are submitted; value quantification and first institutional investment advance the commercial case.
Validation of Solution
The solution is shown to be effective and its value to all stakeholders is validated. Pivotal trial endpoints are achieved, peer-reviewed publications accepted, and purchasing intent from 10+ buyers and a second round of institutional investment are secured.
Approval and Launch
Institutional and regulatory approval received and sales launch executed. Training materials, specialty medical group engagement, initial sales, and reimbursement pathway are established.
Clinical Use
The solution is used successfully in day-to-day clinical practice. Profitable sales, new market launches, ongoing regulatory monitoring, and improvement plans sustain and extend clinical and commercial reach.
Standard of Care
The solution is recognised as the standard of care — recommended by medical specialties, supported by health economics evidence, achieving dominant market share, with product and component obsolescence plans in place.
▾
The 4 Domains
At every IML, progress is tracked across four parallel dimensions — all four must advance together for a project to be on a commercially viable path.
Clinical / Workflow
The clinical evidence, workflow integration, and care pathway development required at each IML — covering how the solution is used by clinicians and health systems.
Market / Business
The commercial validation, stakeholder mapping, and business model development required at each IML — the dimension most commonly under-developed relative to technical progress.
Regulatory
The regulatory strategy, submissions, and approvals required at each IML across relevant jurisdictions — from early engagement through market authorisation and post-market obligations.
Technical / Science
The scientific, engineering, and product development work required at each IML — the bench science, pre-clinical work, and technical development that underpins the clinical and commercial evidence chain.
▾
Solution Types
The 10 IMLs apply universally; the specific Deliverables at each stage depend on the solution type — six types are supported in GAITS, each with a fillable PDF and a platform implementation.
The 10 IMLs and 4 Domains apply to all types of healthcare innovation. What differs between solution types is the specific set of Deliverables required at each stage — the clinical evidence expected, the regulatory pathway, the commercial milestones, and the technical requirements.
Below are links to the free version of GAITS, outlining the Deliverables and associated Resources for each of the solution types that have been developed – with more on the way. They also have links to PDF checklists that can be used independently of the platform.
Access to a private GAITS Solution Site requires an invitation from a Site Admin or Portfolio Manager. All registered users can access the framework guides, glossary, and user documentation without a site invitation.
Sign In or Create AccountInterested in adopting GAITS for your programme? Contact John Collins at jcollins11@mgh.harvard.edu.